124.551 Information program for drug prescribing and dispensing.

351 words·~2 min read·/ia/chapter-124-controlled-substances/124-551

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

1. Contingent upon the receipt of funds pursuant to section 124.557 sufficient to carry out the purposes of this subchapter, the board, in conjunction with the advisory committee created in section 124.555, shall establish and maintain an information program for drug prescribing and dispensing.

2. a. The program shall collect from pharmacies dispensing information for controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, and from first responders as defined in section 147A.1, subsection 7, with the exception of emergency medical care providers as defined in section 147A.1, subsection 4, administration information for opioid antagonists. The department of health and human services shall provide information for the administration of opioid antagonists to the board as prescribed by rule for emergency medical care providers as defined in section 147A.1, subsection 4.

The board shall adopt rules requiring the following information to be provided regarding the administration of opioid antagonists:

(1)Patient identification.

(2)Identification of the person administering opioid antagonists.

(3)The date of administration.

(4)The quantity of opioid antagonists administered.

b. The information collected shall be used by prescribing practitioners, veterinarians, and pharmacists on a need-to-know basis for purposes of improving patient health care by facilitating early identification of patients who may be at risk for addiction, or who may be using, abusing, or diverting drugs for unlawful or otherwise unauthorized purposes at risk to themselves and others, or who may be appropriately using controlled substances lawfully prescribed for them but unknown to the practitioner.

3. The board shall implement technological improvements to facilitate secure access to the program through electronic health and pharmacy information systems. The board shall collect, store, and disseminate program information consistent with security criteria established by rule, including use of appropriate encryption or other industry-recognized security technology.

4. The board shall seek any federal waiver necessary to implement the provisions of the program.

2006 Acts, ch 1147, §2, 11; 2016 Acts, ch 1052, §2; 2017 Acts, ch 54, §76; 2018 Acts, ch 1138, §3; 2020 Acts, ch 1024, §1; 2023 Acts, ch 19, §73; 2024 Acts, ch 1170, §197

Referred to in §22.7(51)